The Discounted Cash Flow (DCF) valuation of AtriCure Inc (ATRC) is (17.81) USD. With the latest stock price at 31.71 USD, the upside of AtriCure Inc based on DCF is -156.2%.
Based on the latest price of 31.71 USD and our DCF valuation, AtriCure Inc (ATRC) is a sell. selling AtriCure stocks now will result in a potential gain of 156.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 10.3% | 8.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (41.36) - (11.29) | (17.81) |
| Upside | -230.4% - -135.6% | -156.2% |